
1. antimicrob agents chemother. 2015 jan;59(1):734-7. doi: 10.1128/aac.03647-14.
epub 2014 nov 17.

in vivo selection plasmodium falciparum pfcrt pfmdr1 variants by
artemether-lumefantrine dihydroartemisinin-piperaquine burkina faso.

baraka v(1), tinto h(2), valea i(2), fitzhenry r(3), delgado-ratto c(4), mbonye
mk(5), van overmeir c(3), rosanas-urgell a(3), van geertruyden jp(4),
d'alessandro u(6), erhart a(3).

author information: 
(1)national institute medical research, tanga medical research centre, tanga,
united republic tanzania international health unit, department of
epidemiology, university antwerp, antwerp, belgium vitobaraka@gmail.com.
(2)centre muraz, bobo dioulasso, burkina faso.
(3)malariology unit, institute tropical medicine, antwerp, belgium.
(4)international health unit, department epidemiology, university antwerp, 
antwerp, belgium.
(5)international health unit, department epidemiology, university antwerp, 
antwerp, belgium infectious diseases institute, makerere university college of
health sciences, kampala, uganda.
(6)malariology unit, institute tropical medicine, antwerp, belgium medical
research council, banjul, gambia london school hygiene tropical
medicine, london, united kingdom.

plasmodium falciparum pfcrt-76 pfmdr1-86 gene polymorphisms determined
during clinical trial burkina faso comparing efficacies of
dihydroartemisinin-piperaquine (dha-ppq) artemether-lumefantrine (al).
significant selection pfcrt-k76 observed exposure al dha-ppq,
as well selection pfmdr1-n86 al dha-ppq treatment, suggesting
reverse selection pfcrt gene ppq. results support rational
use dha-ppq settings chloroquine (cq) resistance high.

copyright Â© 2015, american society microbiology. rights reserved.

doi: 10.1128/aac.03647-14 
pmcid: pmc4291431
pmid: 25403659  [indexed medline]

